ReviewNutrients2026

Microbiota-Associated Metabolites as Biomarkers and Therapeutic Opportunities in Inflammatory Bowel Disease.

Krystian Krysa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.